Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Julian Noble Insider Profile
4 Followers
James Julian Noble, Director at GW Pharma, holds 27.50K shares in GW Pharma (Ticker: GWPH), holds ― shares in Advanced Medical Solutions (Ticker: GB:AMS). Most recently, James Julian Noble Sold ― shares of GW Pharma on May 30, 2019 for an estimated value of 1.27M.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+6.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Julian Noble holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Julian Noble
James Julian Noble's Trading History
GW Pharma
May 30, 2019
Director
Informative Sell
1.27M
$3.57M
Advanced Medical Solutions
―
―
―
List of latest transactions for each holding click on a transaction to see James Julian Noble's performance on stock
You May Also Like
James Julian Noble insider profile FAQ
What is the percentage of profitable transactions made by James Julian Noble?
The percentage of profitable transactions made by James Julian Noble is 67%.
What is the average return per transaction made by James Julian Noble?
The average return per transaction made by James Julian Noble is 6.10%.
What stocks does James Julian Noble hold?
James Julian Noble holds: GWPH, GB:AMS stocks.
What was James Julian Noble’s latest transaction?
James Julian Noble latest transaction was an Informative Sell of $1.27M.
What was James Julian Noble's most profitable transaction?
James Julian Noble’s most profitable transaction was an Informative Sell of GWPH stock on May 30, 2019. The return on the trade was 30.40%.
What is James Julian Noble's role in GW Pharma?
James Julian Noble's role in GW Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.